Krka Enjoys 9% Pharma Sales Growth At The Half-Way Stage

Growth In All Six Geographic Segments Aids Krka; EBITDA Margin Above Guidance

 
• By Dean Rudge
  
Global growth (Vasin Lee/Shutterstock.com)
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business